These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 17868260)

  • 21. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
    Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
    Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
    Sato S; Fujimoto M; Hasegawa M; Takehara K
    Arthritis Rheum; 2004 Jun; 50(6):1918-27. PubMed ID: 15188368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95.
    Jacobi AM; Reiter K; Mackay M; Aranow C; Hiepe F; Radbruch A; Hansen A; Burmester GR; Diamond B; Lipsky PE; Dörner T
    Arthritis Rheum; 2008 Jun; 58(6):1762-73. PubMed ID: 18512812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets.
    Ekşioglu-Demiralp E; Kibaroglu A; Direskeneli H; Yavuz S; Karsli F; Yurdakul S; Yazici H; Akoglu T
    J Rheumatol; 1999 Apr; 26(4):826-32. PubMed ID: 10229403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
    Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
    Carter RH; Zhao H; Liu X; Pelletier M; Chatham W; Kimberly R; Zhou T
    Arthritis Rheum; 2005 Dec; 52(12):3943-54. PubMed ID: 16320342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis.
    Nakano S; Morimoto S; Suzuki J; Mitsuo A; Nakiri Y; Katagiri A; Nozawa K; Amano H; Tokano Y; Hashimoto H; Takasaki Y
    Autoimmunity; 2007 Feb; 40(1):9-15. PubMed ID: 17364492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
    Takasaki Y; Ogaki M; Abe K; Takeuchi K; Ando S; Tokano Y; Kobayashi S; Sekigawa I; Tsuda H; Hashimoto H
    J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients.
    Rastin M; Hatef MR; Tabasi N; Sheikh A; Morad Abbasi J; Mahmoudi M
    Iran J Immunol; 2007 Jun; 4(2):110-5. PubMed ID: 17652851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.
    Mitoma H; Horiuchi T; Kimoto Y; Tsukamoto H; Uchino A; Tamimoto Y; Miyagi Y; Harada M
    Int J Mol Med; 2005 Oct; 16(4):609-15. PubMed ID: 16142394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
    Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
    J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.
    Anolik JH; Barnard J; Cappione A; Pugh-Bernard AE; Felgar RE; Looney RJ; Sanz I
    Arthritis Rheum; 2004 Nov; 50(11):3580-90. PubMed ID: 15529346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M; Kim D; Oh M; Jeong H; Choi I
    Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression.
    Korganow AS; Knapp AM; Nehme-Schuster H; Soulas-Sprauel P; Poindron V; Pasquali JL; Martin T
    J Autoimmun; 2010 Jun; 34(4):426-34. PubMed ID: 19963348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.
    Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O
    Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.